Arnaud Chene
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti-Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike.
Journal: The Journal of infectious diseases
Published: April 03, 2023
Design of bimodular fusion proteins for redirecting a preexisting Epstein-Barr virus antibody response towards defined target cells
Journal: Medecine sciences : M/S
Published: November 30, 2022
Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells.
Journal: International journal of molecular sciences
Published: May 31, 2022
Homeostasis of extracellular ATP in uninfected RBCs from a Plasmodium falciparum culture and derived microparticles.
Journal: Biochimica et biophysica acta. Biomembranes
Published: April 06, 2022
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells.
Journal: Science advances
Published: February 11, 2022
Progress and Insights Toward an Effective Placental Malaria Vaccine.
Journal: Frontiers in immunology
Published: November 27, 2020
VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria.
Journal: Frontiers in immunology
Published: October 30, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: July 16, 2019
VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Journal: Scientific reports
Published: July 03, 2019
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC.
Journal: EBioMedicine
Published: January 14, 2019
Last Updated: 09/26/2026